Indefinite Delivery Contract SPE2DU25D9515

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The $4,999,999 contract, valid through December 31, 2036, covers the delivery of a comprehensive range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. This includes branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The original solicitation, issued under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V), aims to establish multiple prime vendor contracts to provide worldwide pharmaceutical support to various DoD customers, including the Defense Health Agency, Department of Defense, United States Coast Guard, and US Naval Fleet. The $30.3 billion program is structured as a firm-fixed-price, requirements-type contract with a 30-month base period and three 30-month option periods. Awards will be made on a regional basis, with at least three different contractors selected across the North/EUCOM, West/PACOM, South/SOUTHCOM, and Fleet line items to ensure resilience and access to vital pharmaceuticals during contingencies or natural disasters.